Design, synthesis and evaluation of novel retinoic acid receptor (RAR) ligands
by Desai, Shyam N, Ph.D., TEMPLE UNIVERSITY, 2008, 274 pages; 3300344

Abstract:

RARs belong to a super family of nuclear receptors that act as transcription factors. Retinoids bind to RAR subtypes α, β, γ; and RXR subtypes α, β, γ and modulate the activation of these important transcription factors. Retinoids play a vital role in a variety of dermatological disorders and neoplastic diseases due to their effects on cell differentiation, proliferation, and variety of cancer cell lines.

Currently available retinoids exhibit some preference for receptor subtypes but none are considered truly subtype selective and all associated with serious toxicity. A goal in the present research was to synthesize novel RAR compounds with high affinity and improved selectivity for RAR subtypes. This project used a pharmacophoric model, molecular modeling and docking studies, SAR data and structure-based design approaches to design several series of potential RAR ligands.*

Three scaffoldings, namely, tetrahydrobenzoquinolinone (TBQ), chromone and trialkylsilyl acetylenic nuclei, were used to prepare structurally diverse RAR ligands. Well known reactions including Wittigs, Wadsworth-Horner-Emmons, Sonogashira, Friedel-Craft, and DCC coupling were used extensively to provide the target compounds. Molecules selected in modeling studies as possible RAR ligands were synthesized and tested in competitive binding experiments using [3H]-ATRA as the radioligand. This study investigates diverse group of scaffolds ranging from bulky polycyclic heteroaromatic systems (TBQ) to simple aliphatic nuclei. Compounds were identified with moderate affinity for RARs that may exhibit a small degree of receptor selectivity. Lead modification approaches were utilized to alter the structure to provide higher affinity, more selective ligands.*

Based on the limited number of compounds reported herein it appears that several molecular properties should be considered in the design of future ligands. Hence the pharmacophoric model for RAR ligands should be revised to include: (a) IAD—Optimal range of 12.5–15.5 Å. (b) Aliphatic groups in Region A. (c) Planarity and/or linearity especially in Region B. (d) Conjugation between Regions A and C.

The molecules reported herein would be used as leads for the design of higher affinity, more subtype selective RAR ligands in future. The factors described above will be considered in the design of the new RAR ligands.

*Please refer to dissertation for diagrams.

 
AdviserDaniel J. Canney
SchoolTEMPLE UNIVERSITY
SourceDAI/B 69-01, p. , Apr 2008
Source TypeDissertation
SubjectsPharmacology; Pharmaceutical Chemistry
Publication Number3300344
Adobe PDF Access the complete dissertation:
 

» Find an electronic copy at your library.
  Use the link below to access a full citation record of this graduate work:
  http://gateway.proquest.com/openurl%3furl_ver=Z39.88-2004%26res_dat=xri:pqdiss%26rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation%26rft_dat=xri:pqdiss:3300344
  If your library subscribes to the ProQuest Dissertations & Theses (PQDT) database, you may be entitled to a free electronic version of this graduate work. If not, you will have the option to purchase one, and access a 24 page preview for free (if available).

About ProQuest Dissertations & Theses
With over 2.3 million records, the ProQuest Dissertations & Theses (PQDT) database is the most comprehensive collection of dissertations and theses in the world. It is the database of record for graduate research.

The database includes citations of graduate works ranging from the first U.S. dissertation, accepted in 1861, to those accepted as recently as last semester. Of the 2.3 million graduate works included in the database, ProQuest offers more than 1.9 million in full text formats. Of those, over 860,000 are available in PDF format. More than 60,000 dissertations and theses are added to the database each year.

If you have questions, please feel free to visit the ProQuest Web site - http://www.proquest.com - or call ProQuest Hotline Customer Support at 1-800-521-3042.